Risk conferred by tagged SNPs of AGT gene in causing susceptibility to essential hypertension

Clinical and Experimental Hypertension

Volumn 36, Issue 8, 2014, Pages 579-585

  Padma, G ^a   Swapna, N ^a   Mamata, M ^a   Charita, Bh ^b   Padma, T ^a  

^a OSMANIA UNIVERSITY   (India)

^b Andhra Pradesh   (India)

Author keywords

Angiotensinogen; Essential hypertension; Haplotype association; Multifactor dimensionality reduction; Tagged SNPs

Indexed keywords

ANGIOTENSINOGEN; GENETIC MARKER;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENHANCER REGION; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; OBESITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; BIOLOGICAL MODEL; CASE CONTROL STUDY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; MIDDLE AGED; RISK FACTOR;

ANGIOTENSINOGEN; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84902257241     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2014.881845     Document Type: Article

References (41)

1. Borhani NO, Feinleib M, Garrison RJ, et al. Genetic variance in blood pressure. Acta Genet Med Gemellol (Roma) 1976;25: 137-44
2. Friedlander Y, Kark JD, Stein Y. Biological and environmental sources of familial aggregation of blood pressure: the Jerusalem Lipid Research Clinic. Int J Epidemiol 1988;17: 70-6
3. Hong Y, de Faire U, Heller DA, et al. Genetic and environmental influences on blood pressure in elderly twins. Hypertension 1994; 24: 663-70
4. Iselius L, Morton NE, Rao DC. Family resemblance for blood pressure. Hum Hered 1983;33: 277-86
5. Chen P, Jiang YF, Cheng K. Meta-Analysis on the association of AGT M235T polymorphism and essential hypertension in Chinese population. Zhonghua Liu Xing Bing Xue Za Zhi 2003;24: 711-14
6. Kato N, Sugiyama T, Morita H, et al. Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-Analysis on six reported studies. J Hypertens 1999;17: 757-63
7. Kunz R, Kreutz R, Beige J, et al. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997;30: 1331-7
8. Karthikeyan M, Rose R, Shridevi V, et al. Core promoter variants (A-20C, T-18C and G-6A) of the angiotensinogen (AGT) gene are not significantly associated with hypertension in patients of Tamilnadu, India. Int J Hum Genet 2009;9: 13-19
9. Li NF, Zhou L, Wu WD, et al. The relationship between the variants in 50 upstream core promoter A (-6) G and A (-20) C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004;21: 23-8
10. Mondry A, Loh M, Liu P, et al. Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-Analysis of data. BMC Nephrol 2005;6: 1
11. Pereira AC, Mota GFA, Cunha RS, et al. Angiotensinogen 235T allele "dosage" is associated with blood pressure phenotypes. Hypertension 2003;41: 25-30
12. Province MA, Boerwinkle E, Chakravarti A, et al. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program. National Heart, Lung and Blood Institute. J Hypertens 2000;18: 867-76
13. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-Analysis. Arterioscler Thromb Vasc Biol 2003;23: 1269-75
14. Staessen JA, Kuznetsova T, Wang JG, et al. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999;17: 9-17
15. Van den Born BJ, Van Montfrans GA, Uitterlinden, AG, et al. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. J Hypertens 2007;25: 2227-33
16. Corvol P, Persu A, Gimenez-Roqueplo AP, Jeunemaitre X. Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension 1999; 33: 1324-31
17. Hottenga JJ, Whitfield JB, Posthuma D, et al. Genome-wide scan for blood pressure in Australian and Dutch subjects suggests linkage at 5P, 14Q, and 17P. Hypertension 2007;49: 832-8
18. Krushkal J, Ferrell R, Mockrin SC, et al. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Arterioscler Thromb Vasc Biol 1999;19: 427-35
19. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension. Role of angiotensinogen. Cell 1992;71: 169-80
20. Jeunemaitre X, Inoue I, Williams C, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997;60: 1448-60
21. Rodríguez-Pérez JC, Rodríguez-Esparragón F, Herńandez-Perera O, et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the procagene study. J Am Coll Cardiol 2001;37: 1536-42
22. Pereira TV, Nunes ACF, Rudnicki M, et al. Meta-Analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension. A role beyond M235T? Hypertension 2008;51: 778-83
23. Fang YJ, Deng HB, Thomas GN, et al. Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese. J Hypertens 2010;28: 1203-9
24. Ji LD, Zhang LN, Shen P, et al. Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a meta-Analysis. J Hypertens 2010;28: 419-28
25. Vamsi MU, Swapna N, Reddy S, Padma T. Gender related association of AGT gene variants (M235T and T174M) with essential hypertension-A case control study. Clin Exp Hypertens 2012;34: 38-44
26. Charita Bh, Padma G, Sushma P, et al. Estimation of risk and interaction of single nucleotide polymorphisms at angiotensinogen locus causing susceptibility to essential hypertension: a case control study. J Renin Angiotensin Aldosterone Syst 2012;13: 461-71
27. Padma G, Bhupatiraju C, Srinivas B, Padma T. High risk for essential hypertension in males conferred by g.15241A4G polymorphism in intron 3 of AGT gene. Clin Exp Hypertens 2013;35: 108-11
28. Padma G, Charita Bh, Swapna N, et al. Novel variants detected in AGT gene among patients with essential hypertension. J Renin Angiotensin Aldosterone Syst. 2014. [Epub ahead of print]. doi: 10.1177/1470320313513483
29. Lahiri DK, Nurnberger Jr. JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19: 5444
30. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002;34: 88-95
31. Desmet FO, Hamroun D, Lalande M, et al. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009;37: e67
32. Zhang XH, Chasin LA. Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev 2004;18: 1241-50
33. Ishigami T, Umemura S, Tamura K, et al. Essential hypertension and 50 upstream core promoter region of human angiotensinogen gene. Hypertension 1997;30: 1325-45
34. Rahmouni K, Correia MLG, Haynes WG, et al. Obesity-Associated hypertension: new insights into mechanisms. Hypertension 2005; 45: 9-14
35. Narkiewicz K. Obesity and hypertension-The issue is more complex than we thought. Nephrol Dial Transplant 2006;21: 264-7
36. Johnson AD, Ehret GB, Johnson T, et al. Association of hypertension drug target genes with blood pressure and hypertension in 86, 588 individuals. Hypertension 2011;57: 903-10
37. Genome-wide association analysis of blood pressure incorporating gene-Age interactions in the CHARGE, GBPgen, and ICBP Consortia. J. Simino, CHARGE, GBPgen, and ICBP Investigators. St. Louis, MO: Division of Biostatistics, Washington University School of Medicine
38. Li K, Liang Y, Sun Y, et al. The relationship between polymorphisms at 17 gene sites and hypertension among the Aboriginal Tibetan people. Biomed Environ Sci 2012;25: 526-32
39. Williams SM, Addy JH, Phillips III JA, et al. Combination of variants in multiple genes are associated with hypertension. Hypertension 2000;36: 2-6
40. Tsai CT, Fallin D, Chiang FT, et al. Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension 2003;41: 9-15
41. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69: 138-47